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Abstract
Background Financial toxicity has traditionally been attributed to the rising costs of cancer care. As ability to work impacts one’s
financial situation, limited employment and reduced income may also contribute to financial toxicity. We examined evidence of
the association between financial toxicity and employment status in cancer survivors.
Methods A systematic literature review was performed via PubMed, Web of Science, CINAHL, and PsycINFO with search
terms including “Cancer,” “Financial toxicity,” and “Employment” on September 25, 2019.
Results Thirty-one papers met eligibility criteria. Thirteen studies were rated as having high quality, 16 as adequate, and two as
low. Being actively treated for cancer had serious negative consequences on employment and medical expenditures.
Unemployment, changed or reduced employment, lost days at work, poor work ability, and changes to employment were
associated with a higher risk of financial toxicity. Patients who were younger, non-white, unmarried, of low education, living
with dependents, residing in non-metropolitan service areas, with lower income, and of low socioeconomic status were more at
risk of financial toxicity. Other variables associated with financial toxicity included having a mortgage/personal loan, higher out
of pocket costs and household bills, limited health insurance, more severely ill, on active treatment, and lower functioning or
quality of life.
Conclusion Cancer negatively affects employment, and these changes are significant contributors to financial toxicity.
Researchers, healthcare professionals, and patients themselves should all cooperate to tackle these complex issues.
Keywords Financial toxicity . Employment . Cancer survivors . Costs
Abbreviations
MeSH Medical Subject Heading
MM Multiple myeloma
OOP out-of-pocket
PRISMA Preferred Reporting Items for
Systematic Reviews and Meta-Analyses
QOL Quality of life
(USA) United States of America
Introduction
Financial toxicity refers to the financial burden or financial
hardship experienced by cancer survivors because of cancer
and its treatment [1–3]. The problem of financial toxicity is
increasing since the costs of care are increasing with newer
treatments, the prevalence of cancer is growing rapidly, and
many survivors live with cancer as a chronic disease.
Depending on the country and thus the healthcare system,
financial toxicity prevalence varies widely, but studies have
shown consistently that its presence is associated with lower
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quality of life, poorer adherence to or delay of care, and early
mortality [4–7].
High costs of cancer care are a recognized cause of finan-
cial toxicity through medical costs (such as cost of new treat-
ments), non-medical costs (e.g., travel costs to hospitals), or
indirect costs (e.g., lost wages as a result of time off work for
cancer treatment) [5]. Even if healthcare is available to every-
one via universal health insurance coverage, patients have out-
of-pocket expenses (OOP) in relation to their disease and its
treatment. Since many cancer survivors are known to experi-
ence long-term side effects and symptoms of cancer and its
treatment, these costs can continue even years after diagnosis
[8].
To date, a number of systematic reviews have examined
financial toxicity in cancer survivors [2, 9, 10]. A recent re-
view summarized 45 studies and concluded that 47–49% of
cancer survivors reported some degree of financial distress
[9]. Another recent review examined 25 studies from nine
countries with the majority from the USA and showed that
up to 73% of patients reported financial toxicity [2]. Predictors
of financial toxicity included younger age, female gender, a
more recent diagnosis, and use of adjuvant therapies [2]. A
review that focused on the relationship between financial tox-
icity and symptom burden concluded that a clear association
exists between financial toxicity and psychological symptoms
like depression [10].
While the focus on financial toxicity has historically been
on the costs of cancer care, especially in light of the significant
rise in the cost of cancer medicine [11], limitations in or in-
ability to work is also likely to contribute to financial toxicity
[2, 9]. Both income and changes in work participation have
been associated with financial toxicity [2]. Similarly, reduced
income and missed days of work due to illness are associated
with financial hardship [9]. Data on employment after cancer
show that as many as 40% of employed cancer survivors do
not return to work after cancer diagnosis [12], and inability to
work is associated with greater financial hardship and reduced
quality of life [6]. Those more likely to return to work after
diagnosis are individuals with a higher educational level, male
gender, and younger age at diagnosis; those that underwent
less invasive surgery, experienced fewer physical symptoms,
and had a lower length of sick leave; and those with provision
of workplace accommodations such as flexible hours or reha-
bilitation services, lower length of sick leave and continuity of
care [13]. This significant overlap between predictors of finan-
cial toxicity and predictors of unemployment after cancer
raises the question of how employment status and financial
toxicity after cancer are related, taking into account a possi-
bility of confounding.
To address this question, the primary aim of this systematic
literature review was to examine the relationship between fi-
nancial toxicity and employment in cancer survivors and any
variables that may affect this relationship.
Methods
Search strategy
We followed the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines [14]. A
computerized search of the literature through the search en-
gines PubMed, Web of Science, CINAHL, and PsycINFO
was performed on September 25, 2019. The search terms cap-
tured concepts of “financial toxicity,” “employment,” and
“cancer.” Boolean operators and keywords were used with
Medical Subject Headings (MeSH) where possible. Separate
searches were conducted for each database. All search results
were imported in EndNote, which was used to remove dupli-
cates. Reference lists of all identified publications were
checked to retrieve other relevant publications not identified
by means of the computerized search.
Inclusion and exclusion criteria
Studies that met the following criteria were included: (1) if the
objective was to describe financial toxicity and employment in
adult cancer survivors, (2) if the publication described a quan-
titative study, (3) if the publication was an original article
(e.g., no poster abstracts, editorials, reviews, and letters to
the editor), (4) if they were published or in press in peer-
review journals, and (5) if they were written in English.
Studies were excluded for the following reasons: (1) if they
included participants under the age of 18; (2) if they focused
solely on spouses, caregivers, family of cancer survivors, or
health professionals; or (3) if they included patients with other
diseases besides cancer as well.
Screening
Articles were reviewed by title and abstract according to the
pre-specified inclusion and exclusion criteria. Then full-text
papers were reviewed to confirm eligibility. Results of the
search were discussed, and any discrepancies were clarified
until consensus was reached. A flowchart of this selection
procedure is shown in Fig. 1.
Quality assessment
The methodological quality of all included articles was
assessed according to predefined criteria using a 13-item stan-
dardized checklist. The checklist was a slightly adapted ver-
sion of an established criteria list for systematic reviews [15,
16]. The criteria are presented in Table 1.
Each item of an article that matched our criteria received
one point. Zero points were assigned if an item did not meet
our criteria, was described insufficiently, or not at all. The
highest possible score was 13. Studies scoring ≥ 75% of the
5694 Support Care Cancer (2020) 28:5693–5708
Table 1 List of criteria for
assessing the methodological
quality of studies on the
association between financial
toxicity and employment status
Criteria Number of articles
meeting criteria
(n = 31)
Positive if with respect to
Main outcomes
1 A validated financial toxicity questionnaire is used 11
2 Financial toxicity was assessed objectively 2
Study population
3 A description is included of at least two socio-demographic variables 31
4 A description is included of at least two clinical variables 30
5 Inclusion and/or exclusion criteria are described 28
6 Participation rates for patient groups are described and are > 70% 10
7 Information is given about the degree of selection of sample
(e.g., whether there is a selective response)
9
Study design
8 The study size is consisting of at least 50 participants (arbitrarily chosen) 31
9. The collection of data is prospectively gathered 8
10. The process of data collection is described (e.g. interview or self-report) 30
Results
11. The results are compared between two groups or more
(e.g., comparison with healthy population and differences in financial
toxicity between those with or without work), and/or results are
compared between at least two time points (e.g., pre- versus post-treatment)
30
12. Statistical proof for the main findings is reported 30
13. Relationship between financial toxicity and employment status is described 23
Full-text arcles assessed for eligibility (n = 
145)
Records idenfied through database 
searching 
(n = 3945)
Records excluded (n = 114) that did not meet 
our inclusion criteria 
Records aer duplicates removed 
(n = 3260)
Records found through reference checking 
(n =51)



















Records excluded (n = 3115) that did not meet 
our inclusion criteria 
Fig. 1 PRISMA flow diagram
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maximum attainable score (≥ 10 points) were, arbitrarily, con-
sidered to be of “high quality.” Studies scoring between 50
and 75% (7–9 points) were rated as “adequate quality.”
Studies scoring lower than 50% (i.e., < 7 points) of the max-
imum attainable score were considered to be of “low quality.”
Results
Study characteristics
The search identified 3945 unique citations (PubMed (n =
2891), Web of Science (n = 775), CINAHL (n = 180), and
PsycINFO (n = 99)) with 31 studies meeting our inclusion
criteria (Table 2) [8, 17–43]. All were published between
1990 and 2019 and originated from the USA (N = 16),
Australia (N = 6), the Netherlands (N = 2), Canada (n = 1),
Japan (N = 1), Singapore (N = 1), Iran (N = 1), the UK (N =
1), Germany (N = 1), or Ireland (N = 1). A total of 16 studies
reported on data from various tumors [8, 18, 20, 21, 26,
29–33, 36–38, 40, 41, 43], 5 studies focused on breast cancer
[19, 25, 28, 35, 42, 44] and 2 included multiple myeloma
patients [22, 45]. The other studies focused on bladder [39],
prostate [23], colorectal [24], lung [27], head and neck cancer
[34], and bone marrow transplant patients [17]. Time since
diagnosis ranged from a mean of 8.4 months before diagnosis
[27] until a mean of 13 years after diagnosis [19] often had a
broad range, and sometimes was not reported at all. Sample
sizes ranged from 129 [19] to 16,771 [30] participants. Eight
studies had a longitudinal design [19, 24, 25, 27, 32, 35, 42,
44].
Both definitions and measures of financial toxicity varied
strongly, and most measures were not validated making com-
parison between studies difficult. Some studies measured fi-
nancial toxicity by the presence of consequences of increased
costs and decreased income (e.g., bankruptcy, borrowing
money, or debt) [24, 29, 38, 43]. Others measured financial
toxicity by examining OOP costs [16, 21], decreased income
[8, 19, 20, 25–27, 31, 32, 34, 36, 42, 46], the COST tool [40,
43, 45], the Goosens’ cost diary [19], the Breast Cancer
Finances Survey [19], the EORTC QLQ-C30 [18, 28, 33,
34], the Financial Distress/Financial Well-Being scale [21],
and by using questionnaires with self-designed questions.
Only two studies objectively assessed financial toxicity [27,
42] . Employment sta tus was measured as ei ther
unemployment/ceasing working or changes to employment
such as a reduction in work hours.
Quality of studies
The quality of 13 studies included in the reviewwas arbitrarily
rated as high, while 16 studies were rated as adequate quality
and two as having a low quality (Table 2). The primary
limitations of the studies were the lack of information about
the degree of selection of the sample (e.g., whether there is a
selective response), the cross-sectional research designs, and
the lack of a validated financial toxicity measure and/or lack
of objectively assessed financial toxicity.
Financial toxicity and employment among cancer
survivors versus a normative population
Four studies were identified that compared employment be-
tween those with a cancer diagnosis and those who have not
had cancer [8, 20, 24, 37]. The results of 3 cross-sectional
American studies showed that, among those < 64 years of
age, being actively treated for cancer decreased the probability
of employment [20], and increased employment disability [8],
the number of missed workdays per year [8, 20, 37], the num-
ber of days spend in bed [8, 37], and the mean annual medical
expenditures [8, 20, 37], compared with those not having can-
cer. A longitudinal Australian study compared financial strain
between cancer survivors and the general population and con-
cluded that although financial strain was higher in survivors
compared with controls 6 months after diagnosis, it eased and
was comparable with the general population at 12 months
post-diagnosis [24].
The relationship between financial toxicity and
employment
The effect of cancer on financial toxicity and employment
among cancer survivors was examined in all studies. The
quantitative results are summarized in Table 2. Increased fi-
nancial toxicity was associated with both unemployment,
changed or reduced employment, lost days at work, or poor
work ability in almost all included studies [8, 18–22, 24–30,
32–34, 38, 40, 42, 43, 45, 46]. However, a single study from
Ireland identified employed individuals at greater risk for fi-
nancial toxicity since they are more likely to experience a drop
in income due to cancer [41]. Measures of financial toxicity
varied strongly in these studies.
Examining only those studies that measured the impact of
unemployment or ceasing work on financial toxicity identified
twelve studies [18, 21, 24, 29, 30, 33, 38, 40, 45–47]. Half of
the studies examining the impact of unemployment or ceasing
work on financial toxicity have been conducted in the USA
[24, 29, 30, 38, 45–47], only two conducted in Australia [23,
24], and one in Germany [18], the Netherlands [33], Iran [21],
and Japan [40]. Across cancer types, those who were unem-
ployed or ceased employment experienced greater financial
toxicity [18, 21, 24, 29, 33, 40, 45, 46], objective financial
burden (e.g., large decrease in income, selling/second mort-
gage on home, withdrawing money from retirement accounts,
or bankruptcy) [29, 38, 48], or expenses [30] than patients
who remained employed following their diagnosis. In
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contrast, an Irish study among breast and prostate cancer sur-
vivors reported that those who were not working had a signif-
icantly lower risk of cancer-related financial stress compared
with those working (relative risk = 0.71, 95%CI 0.58–0.86)
[41]. A study from the USA including a mixed group of can-
cer survivors concluded that survivors employed at diagnosis
who took extended leave or switched to part-time work were
more likely to report financial hardship (49%) compared with
those employed that did not make changes (20%) and those
who were not employed at diagnosis (17%) [43]. One study
reported that unemployment was significantly associated with
financial hardship while retirement was associated with de-
creased odds of financial hardship [46].
Employment factors associated with financial toxicity
Studies analyzing employment factors associated with finan-
cial toxicity showed that those experiencing less financial
toxicity had the following characteristics: paid leave [17],
those who returned completely to work [21], not working
[41], retired [41], privately insured [41], and those with
higher household savings. Also, a higher age at diagnosis
[40], being white [36, 43], a longer time since diagnosis
[23, 38, 43], a lower disease stage [35], and a higher educa-
tional level [33, 39, 40] decreased the chance of financial
toxicity.
In contrast, those unemployed [29, 33, 38], having to quit a
job [18], taking a new job [18], retire [40], or with a reduction
in work hours [18, 24, 44] because of cancer, those with non-
regular employment [40], with part-time employment at diag-
nosis [44], and those with suboptimal workability [28] report-
ed more financial toxicity. For those unemployed, a longer
time since diagnosis was associated with a lower risk of finan-
cial toxicity but not among those who were employed [33].
Also, individuals reporting higher wage losses who had lower
annual income [35, 36, 38, 41, 44–46], a low socioeconomic
status [33], public insurance [35, 38, 41], poor insurance cov-
erage [29], lack of substantial prescription drug coverage [44],
experienced higher wage losses [42], or were uninsured [35,
38] reported more financial toxicity. Moreover, those who
were younger [29, 31, 33, 35, 38, 39, 43, 44, 46, 49], being
male [33, 41], or female [43], black [35, 39], Spanish-
speaking Latinas [44], unmarried [33, 45], had dependents
[41], residing in a non-metropolitan service area [36], with a
mortgage/personal loan [41], with higher direct OOP costs
[41], and increased household bills [41] reported more finan-
cial toxicity. Also those having two or more cancer diagnoses
[38], a recurrence [44], noninvasive cancer [39], chemothera-
py [22, 35, 44], lymphedema [19], lower physical [29, 49],
mental [29] and socioemotional functioning limitations [49],
and a lower quality of life [33] reported more financial toxic-
ity. No studies analyzed confounders of the association be-
tween financial toxicity and employment.
Discussion
This literature review identified a modest number of studies ex-
amining the relationship between financial toxicity and employ-
ment indicating relative scarcity of data on this subject. In gen-
eral, cancer survivors can lose their job, they may have limita-
tions in the amount or kind ofwork, they can experience job lock
(not being able to take promotions or switch jobs) due to con-
cerns of changing healthcare insurance, and they can experience
higher cost-sharing when insured (especially in the USA) which
can all contribute to financial toxicity. More research in this area
is warranted since data varies between countries according to
differences in healthcare and health insurance systems.
Unemployment, changed or reduced employment, lost days at
work, or poor workability and changes to employment were as-
sociatedwith a higher risk of financial toxicity. However, a single
study identified employment as a risk factor for financial toxicity
among breast and prostate cancer survivors in Ireland [41]. This
finding may reflect differences in health and social care systems
[41]. In Ireland, the healthcare system consists of both private and
public systemswith an income limit determining acceptability for
public services [50]. Those that are above the income limit are not
accepted for public services and therefore pay for private
healthcare. People with private care had higher costs compared
with those in the public system, which suggests that employed
individuals may be more susceptible to greater healthcare costs
and therefore financial strain.
The relationship between negative work changes, and finan-
cial toxicity can be partly explained by the link between employ-
ment and health insurance. In some countries, like the USA,
health insurance is often closely linked with employment.
Therefore, losing one’s job because of cancer entails losing one’s
health insurance. These two factors combined are a major risk
factor for financial toxicity. However, some studies showed a
negative association betweenwork changes and financial toxicity
in the setting of the universal healthcare coverage [24, 33]. This
suggests that the association of employment and financial toxicity
is not only a function of health care insurance but of social secu-
rity systems as well. However, health insurance has an important
role since thosewith private health insurance and paid leave often
experienced a lower risk of financial toxicity while those with
public insurance, those uninsured, thosewith poor insurance cov-
erage, and those with a lack of substantial prescription drug cov-
erage reported a higher risk of financial toxicity.
Differences between countries in employment and financial
toxicity can also be caused by “return to work after cancer” pol-
icies. Return to work is influenced by social security systems,
especially the length of paid sick leave. Furthermore, differences
in legislation, incentives, and possibilities of an employer to pro-
vide employees with return to work programs differ among
countries.
Besides negative work changes, being younger, non-white,
unmarried, of lower education status, and residing with
5705Support Care Cancer (2020) 28:5693–5708
dependents or in non-metropolitan service areas were predic-
tive of a higher risk of financial toxicity. Other factors associ-
ated with a higher risk of financial toxicity were having lower
incomes, low socioeconomic status, a mortgage/personal
loans, higher OOP costs and household bills, non-optimal
health insurance, lower functioning and quality of life, and
being more severely ill or on active treatment. This is not
surprising since financial toxicity is a burden often affecting
those most disadvantaged. These people often have fewer fi-
nancial reserves or support on which to draw in times of un-
expected financial strain. Also, these factors are often nega-
tively associated with employment as well and therefore may
have a compound effect on the likelihood of financial toxicity.
Addressing financial toxicity may assist in addressing issues
of access to care, equity of care, and may have significant
impact on outcomes.
Only four studies compared survivors with a normative pop-
ulation. Three cross-sectional studies from the USA concluded
that being actively treated for cancer had serious negative conse-
quences regarding employment and medical expenditure.
However, one longitudinal Australian study reported differences
in financial strain at 6 months but no differences at 12 months
after diagnosis. Time since diagnosis is thus an important is var-
iable to consider but not all studies take this into consideration.
This systematic review has several strengths including a broad
search of multiple keywords and search terms across various
databases. The quality of most of the studies, as rated by a well-
validated tool,wasmoderate to high.Therewere also a number of
limitations to our study, which should be considered. We specif-
ically targeted studies of adult cancer survivors excluding parents,
siblings, caregivers, and spouses of cancer survivors. This has
restricted the extent to which household financial toxicity can
be examined and its relation to employment, although the impacts
of financial toxicity are seen to extend to the parents, spouses, and
caregivers of survivors [42]. Also, we did not include fully qual-
itative studies. In addition, we only focused on English language
literature.Moreover,most studieswere froma selected number of
countries which limit generalizability across other countries or
healthcare systems. Despite these limitations, this review is the
first to explore the relationship between financial toxicity and
employment among cancer survivors.
cThis reviewdemonstrates the relative paucity of studies in the
area of financial toxicity and employment and highlights a need
for further research into the variables that are associated with the
relationship between financial toxicity and employment to inform
development of interventions to reduce financial toxicity because
of employment change. For instance, the variation by cancer type,
treatment type(s), duration of treatment(s), healthcare provider,
and the role of community, state, and federal policy factors asso-
ciated with financial hardship are still unclear. Further research
should have a longitudinal design in order to focus on how the
relationship between financial toxicity and employment changes
over time. In addition, the use of a control group is warranted
since financial problems can also occur due to other causes then
cancer. In addition, the use of a validated financial toxicity mea-
sure and the use of a standard definition of financial toxicity will
probably lead to results that can be more easily compared be-
tween studies.
In clinical practice, healthcare professionals should screen for
financial toxicity during the disease trajectory. If financial toxicity
is detected, directing patients to financial resources and advocat-
ing with an insurance company on behalf of the patient are pos-
sible actions one could take. Also, financial toxicity should be
discussed with patients after diagnosis and regularly thereafter
because it can influence treatment adherence and thus treatment
efficacy. This is especially relevant in countries without universal
healthcare coverage like the USA. In addition, healthcare profes-
sionals should have attention for the value of certain treatments in
relation to their costs, and they should be prepared to discuss these
tradeoffs with patients. This also implies that healthcare profes-
sionals’ should be informed on the OOP costs related to treat-
ment. Finally, to decrease financial toxicity, patient should have
basic knowledge on health insurance, potential costs of treatment,
and available resources as well.
In conclusion, this review shows that financial toxicity is
common after a cancer diagnosis but varies strongly between
countries since it depends much upon the healthcare system.
Researchers, healthcare professionals, health and safety offi-
cers in the work place, and patients themselves should all
cooperate to tackle these complex issues.
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